For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Glycosyn LLC

USPTO Granted Patents = 20

% Expired Patents = 15.0

EPO Patents = 5

Forward Citations = 56

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

John M McCoy (20 out of 60 patents)

Massimo Merighi (18 out of 18 patents)

Matthew Ian Heidtman (18 out of 18 patents)

4. David S Newburg (4 out of 17 patents)

5. Ardythe L Morrow (2 out of 15 patents)

6. Zhuoteng Yu (2 out of 2 patents)

7. Srikrishnan Mallipeddi (1 out of 1 patent)

8. Phillips W Robbins (7 patents)

9. John M Mccoy (0 patent)

10. Ian Matthew Heidtman (0 patent)

20 patents: Sort by Forward Citations

1. 11643675 - Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides (2023-05-09),

2. 11618912 - Microorganisms and methods for producing sialylated and n-acetylglucosamine-containing oligosaccharides (2023-04-04),

3. 11453900 - Alpha (1,3) fucosyltransferases for use in the production of fucosylated oligosaccharides (2022-09-27),

4. 11331329 - Fucosylated oligosaccharides for prevention of coronavirus infection (2022-05-17),

5. 11324766 - 2'-fucosyllactose for the prevention and treatment of coronavirus-induced inflammation (2022-05-10),

6. 11274325 - Sialyltransferases and uses thereof (2022-03-15),

7. 11236376 - Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides (2022-02-01),

8. 11046984 - Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides (2021-06-29),

9. 11028419 - Biosynthesis of human milk oligosaccharides in engineered bacteria (2021-06-08),

10. 10815511 - Biosynthesis of human milk oligosaccharides in engineered bacteria (2020-10-27),

11. 10487346 - Biosynthesis of human milk oligosaccharides in engineered bacteria (2019-11-26),

12. 10415069 - Microorganisms and methods for producing sialylated and N-acetylglucosamine-containing oligosaccharides (2019-09-17),

13. 10286001 - Use of purified 2'-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics (2019-05-14),

14. 10273516 - Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides (2019-04-30),

15. 9970018 - Biosynthesis of human milk oligosaccharides in engineered bacteria (2018-05-15),

Company Overview

Glycosyn LLC, based in Waltham, MA, specializes in the development of glycosylation technologies and biopharmaceuticals. The company focuses on innovative solutions for the production of glycoproteins and other glycosylated molecules, which are crucial in therapeutic applications. Glycosyn's expertise lies in enhancing the efficacy and safety of biologics through advanced glycoengineering techniques, positioning it as a key player in the biotechnology sector. Their research aims to address complex challenges in drug development and manufacturing processes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

20 Patents

#71 in Waltham, MA

#987 in Massachusetts

#16,409 in US

#31,295 in the World

Waltham, MA, United States of America

Glycosyn LLC

Forward Citations = 56

7 inventors:

John M McCoy (20 out of 60 patents)

Massimo Merighi (18 out of 18 patents)

Matthew Ian Heidtman (18 out of 18 patents)

4. David S Newburg (4 out of 17 patents)

5. Ardythe L Morrow (2 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Glycosyn LLC. Retrieved from https://idiyas.com/company/glycosyn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…